258 related articles for article (PubMed ID: 14617758)
1. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model.
Villadsen LS; Schuurman J; Beurskens F; Dam TN; Dagnaes-Hansen F; Skov L; Rygaard J; Voorhorst-Ogink MM; Gerritsen AF; van Dijk MA; Parren PW; Baadsgaard O; van de Winkel JG
J Clin Invest; 2003 Nov; 112(10):1571-80. PubMed ID: 14617758
[TBL] [Abstract][Full Text] [Related]
2. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder.
Hong K; Chu A; Lúdvíksson BR; Berg EL; Ehrhardt RO
J Immunol; 1999 Jun; 162(12):7480-91. PubMed ID: 10358203
[TBL] [Abstract][Full Text] [Related]
3. IL-1RL2 and its ligands contribute to the cytokine network in psoriasis.
Blumberg H; Dinh H; Dean C; Trueblood ES; Bailey K; Shows D; Bhagavathula N; Aslam MN; Varani J; Towne JE; Sims JE
J Immunol; 2010 Oct; 185(7):4354-62. PubMed ID: 20833839
[TBL] [Abstract][Full Text] [Related]
4. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
Sarra M; Caruso R; Cupi ML; Monteleone I; Stolfi C; Campione E; Diluvio L; Mazzotta A; Botti E; Chimenti S; Costanzo A; MacDonald TT; Pallone F; Monteleone G
J Immunol; 2011 May; 186(9):5435-42. PubMed ID: 21441456
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model.
Nakajima K; Kanda T; Takaishi M; Shiga T; Miyoshi K; Nakajima H; Kamijima R; Tarutani M; Benson JM; Elloso MM; Gutshall LL; Naso MF; Iwakura Y; DiGiovanni J; Sano S
J Immunol; 2011 Apr; 186(7):4481-9. PubMed ID: 21346238
[TBL] [Abstract][Full Text] [Related]
6. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.
Teng X; Hu Z; Wei X; Wang Z; Guan T; Liu N; Liu X; Ye N; Deng G; Luo C; Huang N; Sun C; Xu M; Zhou X; Deng H; Edwards CK; Chen X; Wang X; Cui K; Wei Y; Li J
J Immunol; 2014 Feb; 192(4):1815-23. PubMed ID: 24453242
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model.
Zollner TM; Podda M; Pien C; Elliott PJ; Kaufmann R; Boehncke WH
J Clin Invest; 2002 Mar; 109(5):671-9. PubMed ID: 11877475
[TBL] [Abstract][Full Text] [Related]
8. Possible association of psoriasis and reduced bone mineral density due to increased TNF-alpha and IL-6 concentrations.
Kastelan D; Kastelan M; Massari LP; Korsic M
Med Hypotheses; 2006; 67(6):1403-5. PubMed ID: 16844318
[TBL] [Abstract][Full Text] [Related]
9. AS2762900-00, a potent anti-human IL-23 receptor monoclonal antibody, prevents epidermal hyperplasia in a psoriatic human skin xenograft model.
Sasaki-Iwaoka H; Taguchi K; Okada Y; Imamura E; Kubo S; Furukawa S; Morokata T
Eur J Pharmacol; 2019 Jan; 843():190-198. PubMed ID: 30472202
[TBL] [Abstract][Full Text] [Related]
10. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
11. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
[TBL] [Abstract][Full Text] [Related]
13. Involvement of IL-17F via the induction of IL-6 in psoriasis.
Fujishima S; Watanabe H; Kawaguchi M; Suzuki T; Matsukura S; Homma T; Howell BG; Hizawa N; Mitsuya T; Huang SK; Iijima M
Arch Dermatol Res; 2010 Sep; 302(7):499-505. PubMed ID: 20148256
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte colony-stimulating-factor-induced psoriasiform dermatitis resembles psoriasis with regard to abnormal cytokine expression and epidermal activation.
Mössner R; Beckmann I; Hallermann C; Neumann C; Reich K
Exp Dermatol; 2004 Jun; 13(6):340-6. PubMed ID: 15186319
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse model.
Boehncke WH; Ochsendorf FR; Noll S; Urban M; Popp A; Waldherr D; Haunschild J; Litzenburger T
Br J Dermatol; 2005 Oct; 153(4):758-66. PubMed ID: 16181457
[TBL] [Abstract][Full Text] [Related]
16. 8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder.
Singh TP; Schön MP; Wallbrecht K; Michaelis K; Rinner B; Mayer G; Schmidbauer U; Strohmaier H; Wang XJ; Wolf P
J Immunol; 2010 Jun; 184(12):7257-67. PubMed ID: 20488788
[TBL] [Abstract][Full Text] [Related]
17. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.
Vollmer S; Menssen A; Trommler P; Schendel D; Prinz JC
Eur J Immunol; 1994 Oct; 24(10):2377-82. PubMed ID: 7925564
[TBL] [Abstract][Full Text] [Related]
18. Lesional psoriatic T cells contain the capacity to induce a T cell activation molecule CDw60 on normal keratinocytes.
Skov L; Chan LS; Fox DA; Larsen JK; Voorhees JJ; Cooper KD; Baadsgaard O
Am J Pathol; 1997 Feb; 150(2):675-83. PubMed ID: 9033280
[TBL] [Abstract][Full Text] [Related]
19. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.
Sano S; Chan KS; Carbajal S; Clifford J; Peavey M; Kiguchi K; Itami S; Nickoloff BJ; DiGiovanni J
Nat Med; 2005 Jan; 11(1):43-9. PubMed ID: 15592573
[TBL] [Abstract][Full Text] [Related]
20. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis.
Chan JR; Blumenschein W; Murphy E; Diveu C; Wiekowski M; Abbondanzo S; Lucian L; Geissler R; Brodie S; Kimball AB; Gorman DM; Smith K; de Waal Malefyt R; Kastelein RA; McClanahan TK; Bowman EP
J Exp Med; 2006 Nov; 203(12):2577-87. PubMed ID: 17074928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
